Диссертация (1140821), страница 23
Текст из файла (страница 23)
J Biol Chem. 2007;282(48):35279–35292.158.Nieuwdorp M, Stroes ES, Meijers JC & Bu¨ ller H. Hypercoagulability inthe metabolic syndrome. Current Opinion in harmacology 2005 5 155–159.159.Niger J. Association of pre-eclampsia with metabolic syndrome andincreased risk of cardiovascular disease in women: A systemic review. Clin Pract 2016Jul-Aug;19(4):431-5.160.Niu JM, Lei Q, Lü LJ, Wen JY, Lin XH, Duan DM, Chen X, Zhou YH, MaiCY, Liu GC, Hou MM, Zhao LN, Yi J. of gestational metabolic syndrome and analysisof the risk factors.
Zhonghua Fu Chan Ke Za Zhi. 2013 Feb;48(2):92-7.161.Nohr EA, Bech BH, Davies MJ, Frydenberg M, Henriksen TB, Olsen J.Prepregnancy obesity and fetal death: a study within the Danish National Birth Cohort.Obstet Gynecol. 2005; 106(2):250–259.162.Nohr EA, Vaeth M, Bech BH, Henriksen TB, Cnattingius S, Olsen J.Maternal obesity and neonatal mortality according to subtypes of preterm birth. ObstetGynecol.
2007; 110(5):1083–1090.147163.Nohr EA, Villamor E, Vaeth M, Olsen J, Cnattingius S. Mortality in infantsof obese mothers: is risk modified by mode of delivery? Acta Obstet Gynecol Scand.2012 Mar;91(3):363-71.164.Nuño-Ayala M, Guillén N, Arnal C, Lou-Bonafonte JM, de Martino A,García-de-Jalón JA, Gascón S, Osaba L, Osada J, Navarro MA. Cystathionine βsynthase deficiency causes infertility by impairing decidualization and gene expressionnetworks in uterus implantation sites.
Physiol Genomics. 2012 Jul 15;44(14):702-16.165.O’Brien TE, Ray JG, Chan WS, 2003 Maternal body mass index and therisk of pre-eclampsia: a systematic review. Epidemiology 14: 368-374.166.Oken E, Gillman MW. Fetal origins of obesity. Obes Res. 2003; 11(4):496–506.167.Okereke NC, Huston-Presley L, Amini SB, Kalhan S, Catalano PM.Longitudinal changes in energy expenditure and body composition in obese women withnormal and impaired glucose tolerance. Am J Physiol Endocrinol Metab.
2004;287(3):E472–E479.168.Olufadi R, Byrne CD. Effects of VLDL and remnant particles on platelets.Pathophysiology of Haemostasis and Thrombosis 2006 35 281–291.169.Ozegowska KE, Pawelczyk LA. The role of insulin and selectedadipocytokines in patients with polycystic ovary syndrome (PCOS).
Ginekol Pol 2015Apr;86(4):300-4.170.Pabinger I, Grafenhofer H, Kaider A, et al. Risk of pregnancy-associatedrecurrent venous thromboembolism in women with a history of venous thrombosis. JThromb Haemost. 2005;3:949-954.171.Palomo I, Alarcon M, Moore-Carrasco R & Argiles JM. Hemostasisalterations in metabolic syndrome. International Journal of Molecular Medicine 2006 18969–974.172.Pettila V, Leinonen P, Markkola A, et al. Postpartum bone mineral densityin women treated for thromboprophylaxis with unfractionated heparin or LMW heparin.Thromb Haemost. 2002;87:182-186.148173.Pinheiro MB, Carvalho MG, Martins-Filho OA, Freitas LG, Godoi LC,Alpoim PN, Gomes KB, Dusse LM.
Severe preeclampsia: Are hemostatic andinflammatory parameters associated? Clin Chim Acta. 2013 Oct 8;427C:65-70.174.Poirier P., Giles T.D., Bray G.A. et al. Obesity and cardiovascular disease:pathophysiology, evaluation, and effect of weight loss. Circulation. 2006; 113: 898-918.175.Pomp ER, Lenselink AM, Rosendaal FR, et al. Pregnancy, the postpartumperiod and prothrombotic defects: risk of venous thrombosis in the MEGA study. JThromb Haemost. 2008;6:632-637.176.Pou KM, Massaro JM, Hoffmann U, et al. Visceral and subcutaneousadipose tissue volumes are cross-sectionally related to markers of inflammation andoxidative stress: the Framingham Heart Study.
Circulation. 2007; 16(11):1234–1241.177.Puri M, Kaur L, Walia GK, Mukhopadhhyay R, Sachdeva MP, Trivedi SS,Ghosh PK, Saraswathy KN. MTHFR C677T polymorphism, folate, vitamin B12 andhomocysteine in recurrent pregnancy losses: a case control study among north Indianwomen. J Perinat Med. 2013 Sep 1;41(5):549-54.178.Ramsay JE, Ferrell WR, Crawford L, Wallace AM, Greer IA, Sattar N.Maternal obesity is associated with dysregulation of metabolic, vascular, andinflammatory pathways.
J Clin Endocrinol Metab. 2002; 87(9):4231–4237.179.Randriamboavonjy V, Fleming I. Insulin, insulin resistance, and plateletsignaling in diabetes. Diabetes Care 2009 32 528–530.180.Rao AK, Chitkara U, Milki AA. Subclavian vein thrombosis following IVFand ovarian hyperstimulation: a case report.
Hum Reprod. 2005;20:3307-3312.181.Ray JG, Chan WS. Deep vein thrombosis during pregnancy and thepuerperium: a meta-analysis of the period of risk and the leg of presentation. ObstetGynecol Surv. 1999;54:265-271.182.Ray JG, Wyatt PR, Vermeulen MJ, Meier C, Cole DE.Greater maternalweight and the ongoing risk of neural tube defects after folic acid flour fortification.Obstet Gynecol. 2005 Feb;105(2):261-5.149183.Redmer DA, Luther JS, Milne JS, et al.
Fetoplacental growth and vasculardevelopment in overnourished adolescent sheep at day 50, 90 and 130 of gestation.Reproduction. 2009; 137(4): 749–757.184.Rega G., Kaun C., Weiss T.W. et al. Inflammatory cytokines interleukin-6and oncostatin induce plasminogen activator inhibitor-1 in human adipose tissue.Circulation. 2005; 111: 1938-1945.185.Rega-Kaun G., Kaun C., Wojta J.
More than a simple storage organ:Adipose tissue as a source of adipokines involved in cardiovascular disease. ThrombHaemost. 2013; 110. DOI:10.1160/TH13-03-0212.186.computedRevel M.P., Sanchez O., Dechoux S. et al. Contribution of indirecttomographic venography to the diagnosis of postpartum venousthromboembolism. // J Thromb Haemost 2008; 6: 9: 1478—1481. Rodeck C. Pregnancyreducing.187.Reynolds LP, Borowicz PP, Vonnahme KA, et al. Animal models ofplacental angiogenesis. Placenta. 2005; 26(10):689–708.188.Roberts DJ, Post MD.
The placenta in pre-eclampsia and intrauterinegrowth restriction. J Clin Pathol. 2008; 61(12):1254–1260.189.Roberts VH, Smith J, McLea SA, Heizer AB, Richardson JL, Myatt L.Effect of increasing maternal body mass index on oxidative and nitrative stress in thehuman placenta. Placenta. 2009; 30(2):169–175.190.Robertson L, Wu O, Langhorne P, et al.
Thrombophilia in pregnancy: asystematic review. Br J Haematol. 2006;132:171-196.191.Rumbold AR, Crowther CA, Haslam RR, Dekker GA, Robinson JS; ACTSStudy Group. Vitamins C and E and the risks of preeclampsia and perinatalcomplications. N Engl J Med. 2006 Apr 27;354(17):1796-806.192.Russo I., Traversa M., Bonomo K. et al. In central obesity, weight lossrestores platelet sensitivity to nitric oxide and prostacyclin. Obesity. 2010; 18:788-797.150193.Samad F., Pandey M., de Waard V., Loskutoff D.
Elevated PAI-1 and tissuefactor gene expression in obese mice: a possible mechanism for the increased risk forcardiovascular disease associated with obesity. Fibrinol Proteol. 1997; 11:17.194.Samuelsson AM, Matthews PA, Argenton M, et al. Diet-induced obesity infemale mice leads to offspring hyperphagia, adiposity, hypertension, and insulinresistance: a novel murine model of developmental programming. Hypertension. 2008;51(2):383–392.195.Sandra N, Jana V, Judith M, Marike B, Robin P, Anneke C, Edith J, AndréP, Melanie M, Bruce H.
Associations between smoking, components of metabolicsyndrome and lipoprotein particle size. Slagter et al. BMC Medicine 2013, 11:195.196.Shamshirsaz AA, Paidas M, Krikun G. Preeclampsia, hypoxia, thrombosis,and inflammation. J Pregnancy. 2012;2012:374047.197.Shankar K, Harrell A, Liu X, Gilchrist JM, Ronis MJ, Badger TM.Maternal obesity at conception programs obesity in the offspring.
Am J Physiol RegulIntegr Comp Physiol. 2008; 294(2):R528– R538.198.Shoelson SE, Lee J & Goldfine AB. Inflammation and insulin resistance.Journal of Clinical Investigation 2006 116 1793–1801.199.Silver AE, Beske SD, Christou DD, et al. Overweight and obese humansdemonstrate increased vascular endothelial NAD(P)H oxidase-p47(phox) expressionand evidence of endothelial oxidative stress. Circulation. 2007; 115(5):627–637.200.Silver RM, Parker CB, Reddy UM, Goldenberg R, Coustan D, Dudley DJ,Saade GR, Stoll B, Koch MA, Conway D, Bukowski R, Hogue CJ, Pinar H, Moore J,Willinger M, Branch DW. Antiphospholipid antibodies in stillbirth. Obstet Gynecol.2013 Sep;122(3):641-57.201.Spaan JJ, Sep SJ, van Balen VL, Spaanderman ME, Peeters LL. Metabolicsyndrome as a risk factor for hypertension after preeclampsia. Obstet Gynecol.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
